Product
Currency:CNY
2024/H1
Stock NameRevenueRatio
BRUKINSA/百悦泽8.02B66.84%
TEVIMBRA/百泽安2.19B18.27%
安加维699.47M5.83%
倍利妥238.01M1.98%
凯洛斯213.49M1.78%
普贝希203.36M1.70%
Other191.78M1.60%
瑞复美151.82M1.27%
合作安排收入88.62M0.74%
View all
Industry
Currency:CNY
2024/H1
Stock NameRevenueRatio
Pharmaceutical branch12B100.00%
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
United States of America5.9B49.21%
China's territory4.82B40.21%
Europe1.08B9.00%
Other189.69M1.58%